Skip to content
Toggle Navigation
Home
Pathology School
Cytopathology School
Teaching cases
UPCFBIH
Mucinous carcinoma of the breast (type B, ER+/PR-/Her2 3+) with chemoresistance (Herceptin)
Figure 1. Her2 overexpression in the tumor cells (after neoadjuvant chemoterapy + Herceptin
)
Figure 2. Her2 overexpression in the tumor cells (after neoadjuvant chemoterapy + Herceptin)
Figure 3. Some tumor cells showed 2+ Her2 positivity.
Page load link
Go to Top